Summary
- Revenue
- FOLD current annual revenue is $634.21M, up +20.05% year-over-year
- Next Earnings
- As of today, the next earnings release for FOLD has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Amicus Therapeutics Inc |
| Ticker | NASDAQ: FOLD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | amicusrx.com |
| Employees | 511 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| - | N/A | |
| $634.21M | ||
| Revenue, 1Y Change | +20.05% | |
| -$0.09 | ||
| EPS, 1Y Change | +52.31% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.09 | ||
| EPS Estimate | $0.07 | N/A |
| EPS Est. Change | +182.59% | N/A |
| $634.21M | ||
| Revenue Estimate | $752.43M | N/A |
| Revenue Est. Change | +18.64% | N/A |
| Current Price | - | |
| Price Target | $14.50 | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.24 | -$0.18 | -178.19% | |
| $0.39 | -$0.09 | -122.37% | |
| $0.07 | N/A | +182.59% | |
| $0.82 | N/A | +1,031.63% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $527.02M | $528.30M | +0.24% | |
| $634.00M | $634.21M | +0.03% | |
| $752.43M | N/A | +18.64% | |
| $888.54M | N/A | +40.10% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | - | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A | |
| - | N/A |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $634.21M | ||
| -$0.09 | ||
| $553.82M | ||
| 87.32% | ||
| $34.49M | ||
| 5.44% | ||
| -$27.11M | ||
| -4.27% | ||
| $41.95M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 1.61 | ||
| 2.84 | ||
| 1.88 | ||
| - | ||
| 4 | ||
| - |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $274.24M | ||
| $293.54M | ||
| $949.87M | ||
| $676.17M | ||
| $675.63M | ||
| $237.83M | ||
| $442.36M | ||
| $8.74M | ||
| $28.63M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $661.32M | ||
| $519.33M | ||
| $80.39M | ||
| $383.49M | ||
| $7.46M | ||
| $0.00 | ||
| $27.30M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $33.15M | ||
| -$46.43M | ||
| $610.00K | ||
| $3.30M | ||
| $29.85M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Jefferies | → | |
| Leerink Partners | → | |
| Citigroup | → | |
| Needham | → | |
| Cantor Fitzgerald | → | |
| Citigroup | ||
| JP Morgan | → | |
| Goldman Sachs | → | |
| Needham | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
No data
Screeners with FOLD
FAQ
- What is the ticker symbol for Amicus Therapeutics Inc?
- The ticker symbol for Amicus Therapeutics Inc is NASDAQ:FOLD
- Does Amicus Therapeutics Inc pay dividends?
- No, Amicus Therapeutics Inc does not pay dividends
- What sector is Amicus Therapeutics Inc in?
- Amicus Therapeutics Inc is in the Healthcare sector
- What industry is Amicus Therapeutics Inc in?
- Amicus Therapeutics Inc is in the Biotechnology industry
- What country is Amicus Therapeutics Inc based in?
- Amicus Therapeutics Inc is headquartered in United States
- When did Amicus Therapeutics Inc go public?
- Amicus Therapeutics Inc initial public offering (IPO) was on May 31, 2007
- Is Amicus Therapeutics Inc in the S&P 500?
- No, Amicus Therapeutics Inc is not included in the S&P 500 index
- Is Amicus Therapeutics Inc in the NASDAQ 100?
- No, Amicus Therapeutics Inc is not included in the NASDAQ 100 index
- Is Amicus Therapeutics Inc in the Dow Jones?
- No, Amicus Therapeutics Inc is not included in the Dow Jones index
- When was Amicus Therapeutics Inc last earnings report?
- Amicus Therapeutics Inc's most recent earnings report was on May 4, 2026
- When does Amicus Therapeutics Inc report earnings?
- The date for Amicus Therapeutics Inc's next earnings report has not been announced yet
Data Sources & References
- FOLD Official Website amicusrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1178879/000117887926000005/0001178879-26-000005-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1178879/000117887926000005/0001178879-26-000005-index.htm
- FOLD Profile on Yahoo Finance finance.yahoo.com/quote/FOLD
- FOLD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fold